Free Trial

Coherus BioSciences (CHRS) Short Interest Ratio & Short Volume

$1.66
+0.05 (+3.11%)
(As of 07/12/2024 08:51 PM ET)

Coherus BioSciences Short Interest Data

Current Short Interest
23,040,000 shares
Previous Short Interest
22,200,000 shares
Change Vs. Previous Month
+3.78%
Dollar Volume Sold Short
$39.86 million
Short Interest Ratio
13.8 Days to Cover
Last Record Date
June 30, 2024
Outstanding Shares
114,730,000 shares
Percentage of Shares Shorted
20.08%
Today's Trading Volume
1,445,400 shares
Average Trading Volume
2,904,685 shares
Today's Volume Vs. Average
50%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Coherus BioSciences ?

Sign up to receive the latest short interest report for Coherus BioSciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

CHRS Short Interest Over Time

CHRS Days to Cover Over Time

CHRS Percentage of Float Shorted Over Time

Coherus BioSciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
6/30/202423,040,000 shares $39.86 million +3.8%N/A13.8 $1.73
6/15/202422,200,000 shares $37.52 million +0.6%N/A13.2 $1.69
5/31/202422,060,000 shares $40.15 million +1.3%N/A11.4 $1.82
5/15/202421,780,000 shares $47.48 million +0.4%N/A9.9 $2.18
4/30/202421,690,000 shares $42.51 million +0.7%N/A9.4 $1.96
4/15/202421,530,000 shares $47.37 million -8.2%N/A7.6 $2.20
3/31/202423,450,000 shares $56.05 million -9.5%N/A6.2 $2.39
3/15/202425,910,000 shares $57.52 million +7.1%N/A4.5 $2.22
2/29/202424,200,000 shares $55.18 million -4.4%N/A4.1 $2.28
2/15/202425,320,000 shares $72.16 million -10.0%N/A4.3 $2.85
1/31/202428,130,000 shares $60.48 million +2.6%N/A4.1 $2.15
1/15/202427,430,000 shares $70.50 million +13.2%N/A3.8 $2.57
12/31/202324,230,000 shares $80.69 million +1.9%N/A3.9 $3.33
12/15/202323,770,000 shares $51.58 million +10.8%N/A4.5 $2.17
11/30/202321,460,000 shares $45.71 million -1.1%N/A4.9 $2.13
11/15/202321,690,000 shares $39.04 million +9.3%N/A5.1 $1.80
10/31/202319,840,000 shares $66.46 million +6.0%N/A5.3 $3.35
10/15/202318,720,000 shares $71.32 million +6.4%N/A7 $3.81
9/30/202317,600,000 shares $65.82 million +21.1%N/A6.1 $3.74
9/15/202314,530,000 shares $71.49 million -7.2%N/A4.9 $4.92
8/31/202315,650,000 shares $83.41 million -0.3%N/A4.8 $5.33
8/15/202315,700,000 shares $70.18 million +16.7%N/A4.6 $4.47
7/31/202313,450,000 shares $64.83 million +6.9%N/A3.5 $4.82
7/15/202312,580,000 shares $51.07 million -16.4%N/A3.7 $4.06
6/30/202315,040,000 shares $64.22 million +15.4%N/A4.8 $4.27
6/15/202313,030,000 shares $70.23 million +0.2%N/A4.7 $5.39
5/31/202313,010,000 shares $53.21 million +9.3%N/A6.5 $4.09
5/15/202311,900,000 shares $58.19 million +12.9%N/A7.7 $4.89
4/30/202310,540,000 shares $76.20 million -4.1%N/A9.9 $7.23
4/15/202310,990,000 shares $86.60 million -7.3%N/A11.1 $7.88
3/31/202311,850,000 shares $81.05 million -1.7%N/A11.2 $6.84
3/15/202312,050,000 shares $77.00 million +22.5%N/A9.6 $6.39
2/28/20239,840,000 shares $66.62 million +0.8%N/A8 $6.77
2/15/20239,760,000 shares $77.01 million +2.3%13.4%8.5 $7.89
1/31/20239,540,000 shares $80.90 million -6.2%13.1%7.7 $8.48
1/15/202310,170,000 shares $106.28 million +2.1%14.0%8.1 $10.45
12/30/20229,960,000 shares $78.88 million +2.9%13.7%8 $7.92
12/15/20229,680,000 shares $71.15 million -4.4%13.3%9.2 $7.35
11/30/202210,130,000 shares $69.49 million +1.5%13.9%10 $6.86
11/15/20229,980,000 shares $79.44 million +7.1%13.7%9.2 $7.96
This is HOW many elite traders think (Ad)

Want a preview of how elite traders think?! For a limited time, you can claim AI SMS alerts from TradeAlgo for FREE.

So, hurry and click here to claim your FREE SMS alerts now.
10/31/20229,320,000 shares $81.08 million +0.3%12.8%9 $8.70
10/15/20229,290,000 shares $76.92 million -3.4%12.8%8.6 $8.28
9/30/20229,620,000 shares $92.45 million +2.3%13.2%8.9 $9.61
9/15/20229,400,000 shares $98.98 million -1.2%12.9%8.5 $10.53
8/31/20229,510,000 shares $106.32 million -8.6%13.1%8.6 $11.18
8/15/202210,400,000 shares $144.25 million -1.8%14.3%9.8 $13.87
7/31/202210,590,000 shares $89.70 million +7.5%14.6%9.5 $8.47
7/15/20229,850,000 shares $78.50 million -10.4%13.6%9.2 $7.97
6/30/202210,990,000 shares $79.57 million +13.1%15.2%10.4 $7.24
6/15/20229,720,000 shares $58.22 million -4.6%13.4%9.4 $5.99
5/31/202210,190,000 shares $74.79 million +0.8%14.1%10.8 $7.34
5/15/202210,110,000 shares $80.37 million +16.2%14.0%11.1 $7.95
4/30/20228,700,000 shares $78.65 million +13.7%12.0%9.8 $9.04
4/15/20227,650,000 shares $85.99 million +0.1%10.6%8.7 $11.24
3/31/20227,640,000 shares $98.63 million +9.0%10.6%8.6 $12.91
3/15/20227,010,000 shares $87.91 million -1.3%9.7%8.1 $12.54
2/28/20227,100,000 shares $83.71 million -5.2%9.9%8.2 $11.79
2/15/20227,490,000 shares $98.87 million +13.8%10.4%8.6 $13.20
1/31/20226,580,000 shares $81.33 million -4.1%9.2%8.3 $12.36
1/15/20226,860,000 shares $95.35 million -3.7%9.6%9.7 $13.90
12/31/20217,120,000 shares $113.64 million +4.4%9.9%11.4 $15.96
12/15/20216,820,000 shares $117.24 million -4.5%9.5%10.6 $17.19
11/30/20217,140,000 shares $132.59 million +1.4%9.9%11.2 $18.57
11/15/20217,040,000 shares $133.20 million -6.3%9.8%10.9 $18.92
10/29/20217,510,000 shares $125.64 million -0.1%10.5%10.9 $16.73
10/15/20217,520,000 shares $127.84 million +1.5%10.5%11.5 $17.00
9/30/20217,410,000 shares $119.08 million -13.4%10.4%10.7 $16.07
9/15/20218,560,000 shares $135.16 million -11.9%12.0%12.9 $15.79
8/31/20219,720,000 shares $155.33 million +5.4%13.7%15.1 $15.98
8/13/20219,220,000 shares $128.43 million -1.3%13.0%13.5 $13.93
7/30/20219,340,000 shares $121.89 million +0.2%13.3%13.3 $13.05
7/15/20219,320,000 shares $122.37 million -2.0%13.2%12.4 $13.13
6/30/20219,510,000 shares $131.52 million -1.9%13.5%12.1 $13.83
6/15/20219,690,000 shares $136.73 million -3.2%13.8%11.1 $14.11
5/28/202110,010,000 shares $131.73 million -5.3%14.1%11.1 $13.16
5/14/202110,570,000 shares $146.82 million -5.4%N/A10 $13.89
4/30/202111,170,000 shares $164.20 million -16.8%16.4%10.3 $14.70
4/15/202113,420,000 shares $186.00 million -3.0%19.7%10.2 $13.86
3/31/202113,840,000 shares $199.99 million +1.9%20.3%10.2 $14.45
3/15/202113,580,000 shares $220.68 million +1.2%19.9%10 $16.25
2/26/202113,420,000 shares $204.66 million +2.6%19.7%10.2 $15.25
2/12/202113,080,000 shares $246.17 million -2.3%19.4%11.5 $18.82
1/29/202113,390,000 shares $259.77 million -11.3%19.8%12.2 $19.40
1/15/202115,100,000 shares $271.65 million -2.5%22.4%15.2 $17.99
12/31/202015,490,000 shares $272.16 million +6.1%22.9%17.6 $17.57
12/15/202014,600,000 shares $265.28 million -3.9%21.6%17.2 $18.17
11/30/202015,190,000 shares $282.84 million -3.6%22.5%17.2 $18.62
11/15/202015,760,000 shares $281.16 million -3.1%23.3%17.8 $17.84
10/30/202016,260,000 shares $278.86 million -3.0%24.1%17.9 $17.15
10/15/202016,770,000 shares $306.56 million -5.6%25.1%17.4 $18.28
This is HOW many elite traders think (Ad)

Want a preview of how elite traders think?! For a limited time, you can claim AI SMS alerts from TradeAlgo for FREE.

So, hurry and click here to claim your FREE SMS alerts now.
9/30/202017,760,000 shares $325.72 million -5.9%26.5%18.4 $18.34
9/15/202018,870,000 shares $353.06 million +1.6%28.5%18.7 $18.71
8/31/202018,580,000 shares $352.46 million +3.2%28.1%17.4 $18.97
8/14/202018,010,000 shares $343.45 million -3.3%27.5%12.4 $19.07
7/31/202018,630,000 shares $327.70 million -3.8%28.5%12.3 $17.59
7/15/202019,370,000 shares $337.43 million +2.4%29.8%12.7 $17.42
6/30/202018,920,000 shares $327.88 million +3.4%29.1%10.6 $17.33
6/15/202018,290,000 shares $305.26 million +18.6%28.2%10.3 $16.69
5/29/202015,420,000 shares $281.42 million +10.0%23.8%8.4 $18.25
5/15/202014,020,000 shares $233.01 million +3.8%21.7%8.7 $16.62
4/30/202013,510,000 shares $224.27 million +26.7%20.9%8.9 $16.60
4/15/202010,660,000 shares $154.46 million -3.0%16.5%7.2 $14.49
3/31/202010,990,000 shares $190.46 million -5.4%17.0%8.9 $17.33
3/13/202011,618,200 shares $194.02 million -1.5%18.1%9.1 $16.70
2/28/202011,800,000 shares $167.91 million +1.5%18.3%11.1 $14.23
2/14/202011,630,000 shares $204.11 million +5.5%18.2%11.2 $17.55
1/31/202011,020,000 shares $224.59 million +2.3%17.3%10.2 $20.38
1/15/202010,770,000 shares $232.42 million +7.2%16.9%10.4 $21.58
12/31/201910,050,000 shares $182.41 million +6.7%15.8%9.5 $18.15

CHRS Short Interest - Frequently Asked Questions

What is Coherus BioSciences' current short interest?

Short interest is the volume of Coherus BioSciences shares that have been sold short but have not yet been covered or closed out. As of June 30th, investors have sold 23,040,000 shares of CHRS short. Learn More on Coherus BioSciences' current short interest.

What is a good short interest ratio for Coherus BioSciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. CHRS shares currently have a short interest ratio of 14.0. Learn More on Coherus BioSciences's short interest ratio.

Which institutional investors are shorting Coherus BioSciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Coherus BioSciences: Torno Capital LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Coherus BioSciences' short interest increasing or decreasing?

Coherus BioSciences saw a increase in short interest in June. As of June 30th, there was short interest totaling 23,040,000 shares, an increase of 3.8% from the previous total of 22,200,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Coherus BioSciences' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Coherus BioSciences: REGENXBIO Inc. (8.77%), iTeos Therapeutics, Inc. (9.39%), Adaptive Biotechnologies Co. (8.24%), ProKidney Corp. (15.05%), Lexeo Therapeutics, Inc. (3.59%), Replimune Group, Inc. (12.65%), Valneva SE (0.11%), Allogene Therapeutics, Inc. (30.27%), Alector, Inc. (5.69%), Ocugen, Inc. (20.64%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($3.71 billion), TC Energy Co. ($2.95 billion), Moderna, Inc. ($2.63 billion), Royal Caribbean Cruises Ltd. ($2.53 billion), Paychex, Inc. ($2.03 billion), Cencora, Inc. ($2.03 billion), Tractor Supply ($1.91 billion), Rivian Automotive, Inc. ($1.78 billion), Chesapeake Energy Co. ($1.50 billion), and United Therapeutics Co. ($1.40 billion). View all of the most shorted stocks.

What does it mean to sell short Coherus BioSciences stock?

Short selling CHRS is an investing strategy that aims to generate trading profit from Coherus BioSciences as its price is falling. CHRS shares are trading up $0.05 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Coherus BioSciences?

A short squeeze for Coherus BioSciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CHRS, which in turn drives the price of the stock up even further.

How often is Coherus BioSciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CHRS, twice per month. The most recent reporting period available is June, 30 2024.



This page (NASDAQ:CHRS) was last updated on 7/15/2024 by MarketBeat.com Staff

From Our Partners